Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) announced its participation in three investor conferences in March 2021. The Raymond James 42nd Annual Institutional Investors Conference will feature a fireside chat on March 1 at 9:10 a.m. ET. The Cowen 41st Annual Health Care Conference will include a New Drug Launches panel on March 3 at 10:20 a.m. ET, while the Oppenheimer 31st Annual Healthcare Conference will host another fireside chat on March 17 at 8:40 a.m. ET. Webcasts will be available live and on a 90-day replay via the company’s website.

WALTHAM, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the company will participate in the following investor conferences in March:

• Raymond James 42nd Annual Institutional Investors Conference: Fireside chat on Monday, March 1, 2021 at 9:10 a.m. ET.
  
• Cowen 41st Annual Health Care Conference: New Drug Launches panel on Wednesday, March 3, 2021 at 10:20 a.m. ET.
  
• Oppenheimer 31st Annual Healthcare Conference: Fireside chat on Wednesday, March 17, 2021 at 8:40 a.m. ET.
  

The Raymond James and Oppenheimer Conference events will be available via live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website at https://investors.apellis.com/events-and-presentations. Replays of the webcasts will be available for 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. For more information, please visit www.apellis.com.

Investor Contact:
Argot Partners
apellis@argotpartners.com
212.600.1902

FAQ

What investor conferences will Apellis Pharmaceuticals attend in March 2021?

Apellis will attend the Raymond James, Cowen, and Oppenheimer conferences in March 2021.

When will the Raymond James 42nd Annual Institutional Investors Conference take place?

The Raymond James conference is scheduled for March 1, 2021, at 9:10 a.m. ET.

What is the focus of the Cowen 41st Annual Health Care Conference for Apellis?

Apellis will participate in a New Drug Launches panel at the Cowen conference on March 3, 2021, at 10:20 a.m. ET.

When will Apellis participate in the Oppenheimer 31st Annual Healthcare Conference?

Apellis's fireside chat at the Oppenheimer conference will occur on March 17, 2021, at 8:40 a.m. ET.

How can I access the webcasts of Apellis's presentations during the conferences?

The webcasts will be available live and can be replayed for 90 days following the events on Apellis's website.